Compare · IBM vs OMCL
IBM vs OMCL
Side-by-side comparison of International Business Machines Corporation (IBM) and Omnicell Inc. (OMCL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IBM and OMCL operate in Computer Manufacturing (Technology), so they compete in similar markets.
- IBM is the larger of the two at $215.26B, about 108.7x OMCL ($1.98B).
- IBM has been more active in the news (26 items in the past 4 weeks vs 6 for OMCL).
- IBM has more recent analyst coverage (25 ratings vs 24 for OMCL).
- Company
- International Business Machines Corporation
- Omnicell Inc.
- Price
- $229.00-0.22%
- $43.54+0.14%
- Market cap
- $215.26B
- $1.98B
- 1M return
- -
- +27.61%
- 1Y return
- -
- +69.88%
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 26
- 6
- Recent ratings
- 25
- 24
International Business Machines Corporation
International Business Machines Corporation provides integrated solutions and services worldwide. Its Cloud & Cognitive Software segment offers software for vertical and domain-specific solutions in various application areas; and customer information control system and storage, and analytics and integration software solutions to support client mission on-premise workloads in banking, airline, and retail industries. It also offers middleware and data platform software, including Red Hat that enables the operation of clients' hybrid multi-cloud environments; and Cloud Paks, WebSphere distributed, and analytics platform software, such as DB2 distributed, information integration, and enterprise content management, as well as IoT, Blockchain and AI/Watson platforms. The company's Global Business Services segment offers business consulting services; system integration, application management, maintenance, and support services for packaged software; and finance, procurement, talent and engagement, and industry-specific business process outsourcing services. Its Global Technology Services segment provides IT infrastructure and platform services; and project, managed, outsourcing, and cloud-delivered services for enterprise IT infrastructure environments; and IT infrastructure support services. The company's Systems segment offers servers for businesses, cloud service providers, and scientific computing organizations; data storage products and solutions; and z/OS, an enterprise operating system, as well as Linux. Its Global Financing segment provides lease, installment payment, loan financing, short-term working capital financing, and remanufacturing and remarketing services. The company has a collaboration alliance with GK Software SE to enhance retail innovation and customer omnichannel experience with hybrid cloud technology. The company was formerly known as Computing-Tabulating-Recording Co. The company was incorporated in 1911 and is headquartered in Armonk, New York.
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Latest IBM
- IBM and Aramco Explore Collaboration to Accelerate AI and Innovation Across Saudi Arabia
- Think 2026: IBM Delivers the Blueprint for the AI Operating Model as the AI Divide Widens
- Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein - the Largest Known to Be Simulated with Quantum Computers
- Think 2026: IBM Makes Digital Sovereignty Operational with General Availability of IBM Sovereign Core
- MEDIA ALERT: IBM CEO ARVIND KRISHNA TO OPEN IBM THINK 2026, OUTLINING HOW AI AND QUANTUM WILL DEFINE THE ENTERPRISE
- IBM Study: CEOs are Reshaping C-suite Roles for the AI Era
- International Business Machines Corporation filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- IBM Debuts New AI-Powered Features for the Scuderia Ferrari App
- Private Equity's AI Moment: The Greatest Value Lever in Decades -- and the Hardest to Pull
- SEC Form S-8 POS filed by International Business Machines Corporation
Latest OMCL
- Omnicell to Present at the BofA Securities 2026 Healthcare Conference
- Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer
- Omnicell Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Omnicell Announces First Quarter 2026 Financial Results
- Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026
- SEC Form DEF 14A filed by Omnicell Inc.
- AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards
- SEC Form 4 filed by Njoku Nnamdi
- SEC Form 4 filed by Manley Corey J
- SEC Form 4 filed by Nutt Brian H.